WuXi PharmaTech Hits New 52-Week High at $26.21 (WX)
Shares of WuXi PharmaTech (NYSE:WX) hit a new 52-week high during mid-day trading on Tuesday, AnalystRatingsNetwork.com reports. The stock traded as high as $26.21 and last traded at $26.15, with a volume of 209,421 shares trading hands. The stock had previously closed at $25.25.
Several analysts have recently commented on the stock. Analysts at Janney Montgomery Scott initiated coverage on shares of WuXi PharmaTech (NYSE:WX) in a research note to investors on Thursday, August 15th. They set a “neutral” rating on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of WuXi PharmaTech (NYSE:WX) in a research note to investors on Tuesday, August 13th. They now have a $28.00 price target on the stock, up previously from $24.00. Finally, analysts at Oppenheimer raised their price target on shares of WuXi PharmaTech (NYSE:WX) from $25.00 to $28.00 in a research note to investors on Tuesday, August 13th. They now have an “outperform” rating on the stock.
Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $22.66.
WuXi PharmaTech has a 1-year low of $13.54 and a 1-year high of $26.21. The stock has a 50-day moving average of $23.55 and a 200-day moving average of $20.27. The company has a market cap of $1.858 billion and a P/E ratio of 18.55.
WuXi PharmaTech (NYSE:WX) last posted its quarterly earnings results on Monday, August 12th. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.07. The company had revenue of $142.33 million for the quarter, compared to the consensus estimate of $141.10 million. During the same quarter last year, the company posted $0.33 earnings per share. WuXi PharmaTech’s revenue was up 9.2% compared to the same quarter last year. On average, analysts predict that WuXi PharmaTech will post $1.62 earnings per share for the current fiscal year.
WuXi PharmaTech (NYSE:WX) Inc, (WuXi) is a pharmaceutical, biotechnology and medical device research and development (R&D) outsourcing company, with operations in People’s Republic of China and the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.